Janney Montgomery Scott
HQL

Janney Montgomery Scott’s abrdn Life Sciences Investors HQL Stock Holding History

Janney Montgomery Scott’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Buy
91,519
+3,666
+4% +$61.3K ﹤0.01% 1433
2025
Q4 		$1.47M Buy
87,853
+5,508
+7% +$92.6K ﹤0.01% 1505
2025
Q3 		$1.28M Buy
+82,345
New +$1.13M ﹤0.01% 1549
2025
Q1 		– Sell
-91,398
Closed -$1.2M – 2751
2024
Q4 		$1.2M Buy
91,398
+6,200
+7% +$89.4K ﹤0.01% 1442
2024
Q3 		$1.28M Sell
85,198
-5,669
-6% -$85.8K ﹤0.01% 1368
2024
Q2 		$1.29M Buy
90,867
+4,757
+6% +$64.3K ﹤0.01% 1318
2024
Q1 		$1.17M Buy
86,110
+4,100
+5% +$56.7K ﹤0.01% 1434
2023
Q4 		$1.1M Buy
82,010
+9,761
+14% +$120K ﹤0.01% 1388
2023
Q3 		$901K Buy
72,249
+1,220
+2% +$16K ﹤0.01% 1398
2023
Q2 		$962K Buy
71,029
+3,992
+6% +$55.1K ﹤0.01% 1436
2023
Q1 		$934K Buy
67,037
+6,954
+12% +$99.4K ﹤0.01% 1354
2022
Q4 		$854K Buy
60,083
+4,580
+8% +$66.4K ﹤0.01% 1455
2022
Q3 		$758K Buy
55,503
+8,872
+19% +$133K ﹤0.01% 1450
2022
Q2 		$668K Sell
46,631
-9,090
-16% -$137K ﹤0.01% 1452
2022
Q1 		$922K Buy
55,721
+1,995
+4% +$34.3K ﹤0.01% 1294
2021
Q4 		$1.03M Buy
53,726
+4,595
+9% +$92.5K ﹤0.01% 1311
2021
Q3 		$1.02M Buy
49,131
+827
+2% +$17.7K ﹤0.01% 1265
2021
Q2 		$1.04M Buy
48,304
+5,915
+14% +$119K ﹤0.01% 1254
2021
Q1 		$835K Buy
42,389
+605
+1% +$12.5K ﹤0.01% 1291
2020
Q4 		$825K Buy
41,784
+2,183
+6% +$40.3K ﹤0.01% 1277
2020
Q3 		$696K Sell
39,601
-1,344
-3% -$24.1K ﹤0.01% 1266
2020
Q2 		$735K Sell
40,945
-5,291
-11% -$90.7K ﹤0.01% 1193
2020
Q1 		$693K Sell
46,236
-90
-0.2% -$1.47K 0.01% 1079
2019
Q4 		$807K Buy
46,326
+1,755
+4% +$28.8K 0.01% 1189
2019
Q3 		$673K Buy
44,571
+5,065
+13% +$81.1K ﹤0.01% 1215
2019
Q2 		$666K Buy
39,506
+1,595
+4% +$26.3K 0.01% 1257
2019
Q1 		$649K Sell
37,911
-3,963
-9% -$68.4K 0.01% 1241
2018
Q4 		$633K Buy
41,874
+735
+2% +$12.9K 0.01% 1161
2018
Q3 		$840K Buy
41,139
+1,711
+4% +$34K 0.01% 1134
2018
Q2 		$741K Buy
39,428
+1,609
+4% +$30.3K 0.01% 1158
2018
Q1 		$727K Buy
37,819
+12,227
+48% +$245K 0.01% 1116
2017
Q4 		$502K Buy
25,592
+4,055
+19% +$81.2K 0.01% 1303
2017
Q3 		$463K Buy
21,537
+3,122
+17% +$66.3K 0.01% 1296
2017
Q2 		$384K Buy
18,415
+2,852
+18% +$57.6K ﹤0.01% 1322
2017
Q1 		$302K Buy
15,563
+2,733
+21% +$50.6K ﹤0.01% 1402
2016
Q4 		$218K Buy
+12,830
New +$225K ﹤0.01% 1497

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Janney Montgomery Scott's HQL Position: Q1 2026 in Review

Janney Montgomery Scott increased its abrdn Life Sciences Investors (HQL) stake by 4.2% in Q1 2026, buying an estimated $61.3K and bringing the position to 91,519 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1433.

Janney Montgomery Scott first reported a position in HQL in Q4 2016 and has held it in 36 quarters since. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Janney Montgomery Scott held 91,519 shares of abrdn Life Sciences Investors worth $1.49M as of Q1 2026.
  • Janney Montgomery Scott bought 3,666 abrdn Life Sciences Investors shares in Q1 2026, an estimated $61.3K.
  • abrdn Life Sciences Investors made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #1433 holding.
  • Janney Montgomery Scott first reported a position in abrdn Life Sciences Investors in Q4 2016 and has held it in 36 quarters since.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.